1. , , , et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency. Epilepsia 2009; 50(5):1229–362.
2. . Incidence of seizures during pregnancy, labour and puerperium in epileptic women: a prospective study. Acta Neurol Scand 1987; 75:356–60.
3. , and . The course of epilepsy during pregnancy: a study of 78 cases. Acta Neurol Scand 1988; 78:198–205.
4. , , , et al. Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentration of carbmazepine and phenytoin. Epilepsia 1994; 35:122–30.
5. . Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66:354–60.
6. and . Genetic epidemiology of epilepsy or what do we tell families. Epilepsia 2005; 46(Suppl 10):24–30.
7. . Epilepsy. In: Handbook of Obstetric Medicine, 4th edn. London: Informa UK Limited, 2010: 153–4.
8. , , , et al. Epilepsy and pregnancy: effects of antiepileptic drug use and lifestyle on birthweight. Br J Obstet Gynaecol 2000; 107:896–902.
9. , , , et al. Community-based prospective controlled study of obstetrical and neonatal oucome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47(1):186–92.
10. , , , et al. Pregnancy, delivery and outcome for the child in maternal epilepsy. Epilepsia 2009; 50(9):2130–39.
11. , and . Obstetric outcome in women with epilepsy. Am J Obstet Gynecol 1985; 152(5):499–504.
12. , , , et al. Epilepsy and pregnancy: an obstetric perspective. Am J Obstet Gynecol 2004; 190:371–9.
13. , , , et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes. Epilepsia 2009; 50(5):1237–46.
14. , , , et al. Obstetric outcome in women with epilepsy: a hospital-based retrospective study. BJOG 2011; 118:956–65.
15. , , , et al. Delivery outcome of women with epilepsy: population-based cohort study. BJOG 2010; 117:1537–43.
16. . Managing epilepsy in women of childbearing age. Drug Saf 2009; 32(4):293–307.
17. . The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003; 25(11):959–65.
18. , , , et al. Canadian guidelines for prenatal diagnosis. Techniques of prenatal diagnosis. SOGC Clinical Practice Guidelines, No.105, July 2001. J Obstet Gynaecol Can 2001; 23(7):616–24.
19. and . Fetal face and central nervous system. In: , , eds. Textbook of fetal ultrasound. New York, NY: Parthenon, 1999; 109–11.
20. and . Sonography of fetal cerebrospinal anomalies. Prenat Diagn 2002; 22:321–30.
21. . Complications during pregnancy and delivery. In: , , , et al., eds. Epilepsy and pregnancy. Chichester: Wrightson Biomedical Publishing Ltd, 1997; 105–11.
22. , , , et al. Heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979; 7(1):3–6.
23. , , , et al. AED in pregnancy and hemorrhagic disease of the newborn: an update. Can Fam Physician 2010; 56:1291–2.
24. , , , et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence based review): vitamin K, folic acid, blood levels, and breastfeeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009; 73(2):142–9.